Variant report

Variant	nsv1031258
Chromosome Location	chr4:186979699-187060255
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:186989219-186989538	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:187058552-187058902	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:187058644-187058864	K562	blood:	n/a	n/a
4	ATF1	chr4:187027151-187027480	K562	blood:	n/a	n/a
5	ATF2	chr4:187055315-187055866	GM12878	blood:	n/a	n/a
6	ATF2	chr4:186979842-186980247	GM12878	blood:	n/a	n/a
7	ATF2	chr4:187027166-187027483	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr4:187025719-187026243	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr4:187026701-187026862	H1-hESC	embryonic stem cell:	n/a	n/a
10	BATF	chr4:186979789-186980186	GM12878	blood:	n/a	n/a
11	BATF	chr4:187058431-187058728	GM12878	blood:	n/a	n/a
12	BATF	chr4:187055371-187055785	GM12878	blood:	n/a	n/a
13	BATF	chr4:187058420-187058694	GM12878	blood:	n/a	n/a
14	BATF	chr4:187055418-187055866	GM12878	blood:	n/a	n/a
15	BCL11A	chr4:186979854-186980169	GM12878	blood:	n/a	n/a
16	BCL11A	chr4:186979842-186980224	GM12878	blood:	n/a	n/a
17	BCL11A	chr4:187055420-187055843	GM12878	blood:	n/a	n/a
18	BCL3	chr4:187055433-187055716	GM12878	blood:	n/a	n/a
19	BCL3	chr4:186979857-186980236	GM12878	blood:	n/a	n/a
20	BCL3	chr4:186979865-186980155	GM12878	blood:	n/a	n/a
21	BCL3	chr4:187059720-187060074	GM12878	blood:	n/a	n/a
22	BCLAF1	chr4:187055345-187055835	GM12878	blood:	n/a	n/a
23	BCLAF1	chr4:187055428-187055813	GM12878	blood:	n/a	n/a
24	BHLHE40	chr4:187059455-187059456	GM12878	blood:	n/a	n/a
25	BHLHE40	chr4:187039012-187039026	K562	blood:	n/a	n/a
26	BHLHE40	chr4:187055496-187055825	GM12878	blood:	n/a	n/a
27	CBX3	chr4:186989030-186989622	HCT-116	colon:	n/a	chr4:186989176-186989187
28	CEBPB	chr4:187037865-187038243	K562	blood:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
29	CEBPB	chr4:187037867-187038233	HepG2	liver:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
30	CEBPB	chr4:187037849-187038207	ECC-1	luminal epithelium:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
31	CEBPB	chr4:187058752-187058939	K562	blood:	n/a	n/a
32	CEBPB	chr4:187058612-187058894	A549	lung:	n/a	n/a
33	CEBPB	chr4:187009826-187010155	HepG2	liver:	n/a	chr4:187009905-187009916
34	CEBPB	chr4:187037868-187038236	A549	lung:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
35	CEBPB	chr4:186982076-186982118	HepG2	liver:	n/a	chr4:186982090-186982101
36	CEBPB	chr4:187037859-187038158	MCF-7	breast:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
37	CEBPB	chr4:187037900-187038225	A549	lung:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
38	CEBPB	chr4:187059932-187059959	HepG2	liver:	n/a	n/a
39	CEBPB	chr4:187037881-187038220	Hela-S3	cervix:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
40	CEBPB	chr4:187037847-187038225	ECC-1	luminal epithelium:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
41	CEBPB	chr4:187037872-187038236	IMR90	lung:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
42	CEBPB	chr4:187037874-187038237	H1-hESC	embryonic stem cell:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
43	CEBPB	chr4:186990084-186990532	Hela-S3	cervix:	n/a	n/a
44	CEBPB	chr4:187037845-187038266	A549	lung:	n/a	chr4:187038050-187038059 chr4:187038050-187038059 chr4:187038048-187038061 chr4:187038050-187038059 chr4:187038048-187038059
45	CHD1	chr4:187026105-187026212	H1-hESC	embryonic stem cell:	n/a	chr4:187026142-187026152
46	CHD1	chr4:187059861-187059865	GM12878	blood:	n/a	n/a
47	CHD2	chr4:187055449-187055790	GM12878	blood:	n/a	n/a
48	CHD2	chr4:187000118-187000352	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD2	chr4:187002365-187002951	H1-hESC	embryonic stem cell:	n/a	n/a
50	CTBP2	chr4:187025588-187026455	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:186990315-186990365	Caco-2	colon:	n/a
2	chr4:187026225-187026275	SK-N-MC	brain:	n/a
3	chr4:186990315-186990365	Caco-2	colon:	n/a
4	chr4:187026225-187026275	SK-N-MC	brain:	n/a
5	chr4:187003000-187003050	AG04449	skin:	fetal
6	chr4:186990202-186990252	A549	lung:	n/a
7	chr4:187026872-187026922	HCT-116	colon:	n/a
8	chr4:187025897-187025947	Jurkat	blood:	n/a
9	chr4:187026710-187026760	AG09319	gingival:	n/a
10	chr4:187026970-187027020	T-47D	breast:	n/a
11	chr4:187026872-187026922	Jurkat	blood:	n/a
12	chr4:187002617-187002667	NHDF-neo	bronchial:	n/a
13	chr4:186990202-186990252	GM06990	blood:	n/a
14	chr4:187023193-187023243	AG04450	lung:	fetal
15	chr4:186990202-186990252	HMEC	breast:	n/a
16	chr4:187053574-187053624	HCT-116	colon:	n/a
17	chr4:187026872-187026922	AG10803	skin:	n/a
18	chr4:187026970-187027020	GM12892	blood:	n/a
19	chr4:187013645-187013695	SK-N-SH_RA	brain:	n/a
20	chr4:186990324-186990374	SKMC	muscle:	n/a
21	chr4:187013645-187013695	HEEpiC	esophagus:	n/a
22	chr4:186990324-186990374	BJ	skin:	n/a
23	chr4:187013536-187013586	NT2-D1	testis:	n/a
24	chr4:187025654-187025704	PANC-1	pancreas:	n/a
25	chr4:187023193-187023243	GM06990	blood:	n/a
26	chr4:187026225-187026275	HRPEpiC	eye:	n/a
27	chr4:187026970-187027020	AG10803	skin:	n/a
28	chr4:187025654-187025704	NB4	blood:	n/a
29	chr4:186990315-186990365	GM12878	blood:	n/a
30	chr4:186990324-186990374	AG04450	lung:	fetal
31	chr4:186990315-186990365	ECC-1	luminal epithelium:	n/a
32	chr4:187025420-187025470	Jurkat	blood:	n/a
33	chr4:186990425-186990475	U87	brain:	n/a
34	chr4:187000846-187000896	GM12892	blood:	n/a
35	chr4:186990315-186990365	GM19239	blood:	n/a
36	chr4:187026710-187026760	PrEC	prostate:	n/a
37	chr4:187013536-187013586	IMR90	lung:	fetal
38	chr4:187025886-187025936	MCF-7	breast:	n/a
39	chr4:187025420-187025470	HL-60	blood:	n/a
40	chr4:187037318-187037368	ProgFib	skin:	n/a
41	chr4:187025897-187025947	HEEpiC	esophagus:	n/a
42	chr4:187026225-187026275	PANC-1	pancreas:	n/a
43	chr4:186990315-186990365	HEK293	kidney:	embryo
44	chr4:187026710-187026760	PANC-1	pancreas:	n/a
45	chr4:186990324-186990374	HRE	kidney:	n/a
46	chr4:187003000-187003050	SK-N-SH	brain:	n/a
47	chr4:187000846-187000896	SK-N-SH	brain:	n/a
48	chr4:186990315-186990365	HCM	heart:	n/a
49	chr4:186990006-186990056	LNCaP	prostate:	n/a
50	chr4:187026225-187026275	HUVEC	blood vessel:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:186988895..186989419-chr4:187058283..187058978,2	K562	blood:
2	chr4:186988972..186989928-chr4:187122701..187123491,2	MCF-7	breast:
3	chr4:187053833..187057505-chr4:187060435..187064133,3	K562	blood:
4	chr4:187036166..187038039-chr4:187110587..187113537,2	K562	blood:
5	chr4:186988828..186989568-chr4:187053779..187054412,2	MCF-7	breast:
6	chr4:187002937..187005829-chr4:187012756..187015507,2	MCF-7	breast:
7	chr4:186988859..186989716-chr4:187058329..187059203,5	MCF-7	breast:
8	chr4:187021448..187022968-chr6:31674535..31677393,2	K562	blood:
9	chr4:187023730..187026664-chr4:187030524..187032198,2	MCF-7	breast:
10	chr4:187009172..187011759-chr4:187017494..187019918,3	K562	blood:
11	chr4:187000465..187002106-chr4:187010501..187012706,2	MCF-7	breast:
12	chr4:186953201..186953720-chr4:187058277..187058867,2	MCF-7	breast:
13	chr4:186981542..186984257-chr4:186986669..186988190,2	MCF-7	breast:
14	chr4:186981542..186984257-chr4:186986669..186988190,2	MCF-7	breast:
15	chr4:187009172..187011759-chr4:187017494..187019918,3	K562	blood:
16	chr4:187058298..187058901-chr4:187122712..187123588,2	MCF-7	breast:
17	chr4:187053677..187057505-chr4:187060435..187064236,4	K562	blood:
18	chr4:187002937..187005829-chr4:187012756..187015507,2	MCF-7	breast:
19	chr4:186988828..186989568-chr4:187053779..187054412,2	MCF-7	breast:
20	chr4:186985477..186986987-chr4:187047828..187050010,2	K562	blood:
21	chr4:186988895..186989419-chr4:187058283..187058978,2	K562	blood:
22	chr4:186988859..186989716-chr4:187058329..187059203,5	MCF-7	breast:
23	chr4:187000465..187002106-chr4:187010501..187012706,2	MCF-7	breast:
24	chr4:186985477..186986987-chr4:187047828..187050010,2	K562	blood:

Variant related genes	Relation type
ENSG00000253013	TF binding region
FAM149A	TF binding region
TLR3	TF binding region
ENSG00000253013	CpG island
FAM149A	CpG island
TLR3	CpG island
ENSG00000204424	chromatin interactions
ENSG00000145476	chromatin interactions
ENSG00000269302	chromatin interactions
ENSG00000109794	chromatin interactions
ENSG00000250641	chromatin interactions

Extended variants
information (count: 3425 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:3425 , 50 per page) page: 1 2 3 4 5 6 7 ... 69

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7678294	chr4:186979699-186979700	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs146430223	chr4:186979756-186979757	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs539588397	chr4:186979792-186979793	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs373013573	chr4:186979793-186979794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs531017093	chr4:186979804-186979805	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs557357541	chr4:186979848-186979849	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs569987457	chr4:186979857-186979858	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs73873705	chr4:186979880-186979881	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs555280714	chr4:186979895-186979896	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs550726564	chr4:186979916-186979917	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs572243005	chr4:186979946-186979947	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs140765994	chr4:186979952-186979953	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs114575070	chr4:186979968-186979969	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs577299847	chr4:186979992-186979993	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs567443363	chr4:186980000-186980001	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs536324259	chr4:186980026-186980027	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs543027728	chr4:186980032-186980033	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs562900688	chr4:186980047-186980048	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs529572302	chr4:186980070-186980071	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
20	rs183659642	chr4:186980108-186980109	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
21	rs559793958	chr4:186980152-186980153	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
22	rs144686593	chr4:186980160-186980161	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
23	rs73873706	chr4:186980161-186980162	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
24	rs117778070	chr4:186980175-186980176	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
25	rs34477087	chr4:186980178-186980179	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
26	rs530999240	chr4:186980181-186980182	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
27	rs369632812	chr4:186980196-186980197	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
28	rs373495720	chr4:186980268-186980269	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs57692342	chr4:186980317-186980318	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs141068248	chr4:186980323-186980324	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs201154094	chr4:186980417-186980418	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs79588688	chr4:186980425-186980426	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs555679210	chr4:186980442-186980443	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs187882388	chr4:186980470-186980471	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs372246012	chr4:186980496-186980497	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs150242109	chr4:186980500-186980501	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs192924075	chr4:186980516-186980517	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs577324296	chr4:186980540-186980541	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs9991850	chr4:186980561-186980562	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs575571556	chr4:186980570-186980571	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs10014549	chr4:186980596-186980597	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs369119477	chr4:186980606-186980607	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs370138874	chr4:186980618-186980619	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs72705078	chr4:186980697-186980698	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs11944323	chr4:186980699-186980700	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs185018736	chr4:186980742-186980743	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs114473134	chr4:186980774-186980775	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs545639939	chr4:186980790-186980791	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs565431306	chr4:186980809-186980810	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs28811953	chr4:186980866-186980867	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
abnormal development	18461090	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16774939	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	17053054	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Facioscapulohumeral muscular dystrophy	21829175	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	17086460	CNVD
Autism	18414403	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Prostate cancer	22341455	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:1288 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:186972600-186980000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr4:186979200-186980200	Enhancers	Primary B cells from cord blood	blood
3	chr4:186979200-186980800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
4	chr4:186979400-186980200	Enhancers	GM12878-XiMat	blood
5	chr4:186979400-186980400	Enhancers	Primary B cells from peripheral blood	blood
6	chr4:186979400-186980400	Enhancers	Primary T killer memory cells from peripheral blood	blood
7	chr4:186979600-186980200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr4:186979600-186980200	Enhancers	Monocytes-CD14+_RO01746	blood
9	chr4:186979800-186980000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr4:186979800-186980200	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr4:186979800-186980200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
12	chr4:186979800-186980200	Enhancers	Primary hematopoietic stem cells	blood
13	chr4:186979800-186980200	Enhancers	Primary hematopoietic stem cells short term culture	blood
14	chr4:186979800-186980200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
15	chr4:186979800-186980200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
16	chr4:186979800-186980200	Enhancers	Primary T helper cells PMA-I stimulated	--
17	chr4:186979800-186980200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
18	chr4:186979800-186980200	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
19	chr4:186979800-186980400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr4:186980000-186980200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr4:186980000-186980200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
22	chr4:186980000-186980200	Enhancers	Spleen	Spleen
23	chr4:186980000-186980400	Enhancers	Primary T helper cells fromperipheralblood	blood
24	chr4:186980200-186980400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr4:186980200-186989200	Weak transcription	Monocytes-CD14+_RO01746	blood
26	chr4:186985000-186989000	Weak transcription	Left Ventricle	heart
27	chr4:186986800-186987000	Enhancers	HepG2	liver
28	chr4:186987200-186987400	Enhancers	Brain Hippocampus Middle	brain
29	chr4:186987200-186988200	Enhancers	Brain Germinal Matrix	brain
30	chr4:186987200-186988800	Weak transcription	HepG2	liver
31	chr4:186987400-186989000	Weak transcription	Brain Hippocampus Middle	brain
32	chr4:186988200-186989400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr4:186988200-186989800	Weak transcription	Brain Germinal Matrix	brain
34	chr4:186988400-186988800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr4:186988400-186989200	Enhancers	Breast Myoepithelial Primary Cells	Breast
36	chr4:186988800-186989000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr4:186988800-186989000	Enhancers	Colon Smooth Muscle	Colon
38	chr4:186988800-186989200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr4:186988800-186989200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr4:186988800-186989200	Enhancers	Duodenum Smooth Muscle	Duodenum
41	chr4:186988800-186989200	Enhancers	HepG2	liver
42	chr4:186988800-186989200	Enhancers	NHDF-Ad	bronchial
43	chr4:186988800-186989400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
44	chr4:186988800-186989400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
45	chr4:186989000-186989200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr4:186989000-186989200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
47	chr4:186989000-186989200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
48	chr4:186989000-186989200	Enhancers	Primary T killer memory cells from peripheral blood	blood
49	chr4:186989000-186989200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr4:186989000-186989200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links